Targeting α7 nicotinic acetylcholine receptors for chronic pain

Despite rapid advances in the field of chronic pain, it remains extremely challenging in the clinic. Pain treatment strategies have not improved for decades as opioids remain the main prescribed drugs for chronic pain management. However, long-term use of opioids often leads to detrimental side effects. Therefore, uncovering the mechanisms underlying the development and maintenance of chronic pain may aid the discovery of novel therapeutics to benefit patients with chronic pain. Substantial evidence indicates downregulation of α7 nicotinic acetylcholine receptors (α7 nAChR) in the sciatic nerve, dorsal root ganglia, and spinal cord dorsal horn in rodent models of chronic pain. Moreover, our recent study and results from other laboratories demonstrate that potentiation of α7 nAChR attenuates pain behaviors in various murine models of chronic pain. This review summarized and discussed the preclinical evidence demonstrating the therapeutic potential of α7 nAChR agonists and allosteric modulators in chronic pain. This evidence indicates that potentiation of α7 nAChR is beneficial in chronic pain, mostly by alleviating neuroinflammation. Overall, α7 nAChR-based therapy for chronic pain is an area with great promise, but more research regarding its detailed mechanisms is warranted.

[1]  G. Guy,et al.  Patterns in Nonopioid Pain Medication Prescribing After the Release of the 2016 Guideline for Prescribing Opioids for Chronic Pain , 2022, JAMA network open.

[2]  W. Mei,et al.  Sestrin2 overexpression attenuates osteoarthritis pain via induction of AMPK/PGC-1α-mediated mitochondrial biogenesis and suppression of neuroinflammation , 2022, Brain, Behavior, and Immunity.

[3]  Wen-tao Liu,et al.  AMPK-autophagy-mediated inhibition of microRNA-30a-5p alleviates morphine tolerance via SOCS3-dependent neuroinflammation suppression , 2022, Journal of neuroinflammation.

[4]  M. Treinin,et al.  Neuroinflammation Modulation via α7 Nicotinic Acetylcholine Receptor and Its Chaperone, RIC-3 , 2021, Molecules.

[5]  Lina Huang,et al.  The role of dorsal root ganglia alpha-7 nicotinic acetylcholine receptor in complete Freund’s adjuvant-induced chronic inflammatory pain , 2021, Inflammopharmacology.

[6]  D. Bredt,et al.  Nicotinic acetylcholine receptor redux: Discovery of accessories opens therapeutic vistas , 2021, Science.

[7]  H. Arias,et al.  (E)-3-furan-2-yl-N-phenylacrylamide (PAM-4) decreases nociception and emotional manifestations of neuropathic pain in mice by α7 nicotinic acetylcholine receptor potentiation , 2021, Neurological research.

[8]  C. Ghelardini,et al.  Pain Relieving and Neuroprotective Effects of Non-opioid Compound, DDD-028, in the Rat Model of Paclitaxel-Induced Neuropathy , 2021, Neurotherapeutics.

[9]  R. Papke,et al.  Therapeutic Targeting of α7 Nicotinic Acetylcholine Receptors , 2021, Pharmacological Reviews.

[10]  Wen Zhang,et al.  GLP-1R activation ameliorated novel-object recognition memory dysfunction via regulating hippocampal AMPK/NF-κB pathway in neuropathic pain mice , 2021, Neurobiology of Learning and Memory.

[11]  Jun Hu,et al.  Stimulation of α7-nAChRs coordinates autophagy and apoptosis signaling in experimental knee osteoarthritis , 2021, Cell Death & Disease.

[12]  T. Han,et al.  Autophagy is Involved in Neuroprotective Effect of Alpha7 Nicotinic Acetylcholine Receptor on Ischemic Stroke , 2021, Frontiers in Pharmacology.

[13]  Boyi Liu,et al.  The NLRP3 inflammasome: an emerging therapeutic target for chronic pain , 2021, Journal of Neuroinflammation.

[14]  R. Ostrom,et al.  Anti‐inflammatory effects of α7‐nicotinic ACh receptors are exerted through interactions with adenylyl cyclase‐6 , 2021, British journal of pharmacology.

[15]  F. Gao,et al.  The Spinal α7-Nicotinic Acetylcholine Receptor Contributes to the Maintenance of Cancer-Induced Bone Pain , 2021, Journal of pain research.

[16]  Li-Lian Yuan,et al.  The nAChR Chaperone TMEM35a (NACHO) Contributes to the Development of Hyperalgesia in Mice , 2021, Neuroscience.

[17]  K. Candiotti,et al.  The role of α7-nicotinic acetylcholine receptor in a rat model of chronic nicotine-induced mechanical hypersensitivity , 2020, Neuroscience Letters.

[18]  Yongxiang Wang,et al.  Cynandione A Alleviates Neuropathic Pain Through α7-nAChR-Dependent IL-10/β-Endorphin Signaling Complexes , 2021, Frontiers in Pharmacology.

[19]  R. Papke,et al.  Effects of α7 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator on BDNF, NKCC1 and KCC2 Expression in the Hippocampus following Lipopolysaccharide-induced Allodynia and Hyperalgesia in a Mouse Model of Inflammatory Pain. , 2020, CNS & neurological disorders drug targets.

[20]  H. Arias,et al.  (E)-3-Furan-2-yl-N-p-tolyl-acrylamide and its Derivative DM489 Decrease Neuropathic Pain in Mice Predominantly by α7 Nicotinic Acetylcholine Receptor Potentiation. , 2020, ACS chemical neuroscience.

[21]  J. McIntosh,et al.  Behavioral and Molecular Basis of Cholinergic Modulation of Pain: Focus on Nicotinic Acetylcholine Receptors. , 2020, Current topics in behavioral neurosciences.

[22]  Yong-Jing Gao,et al.  Chemokines in chronic pain: cellular and molecular mechanisms and therapeutic potential. , 2020, Pharmacology & therapeutics.

[23]  E. E. Bagley,et al.  Endogenous opioid peptides in the descending pain modulatory circuit , 2020, Neuropharmacology.

[24]  T. Kosten,et al.  One-day tropisetron treatment improves cognitive deficits and P50 inhibition deficits in schizophrenia , 2020, Neuropsychopharmacology.

[25]  Yongxiang Wang,et al.  The spinal microglial IL-10/β-endorphin pathway accounts for cinobufagin-induced mechanical antiallodynia in bone cancer pain following activation of α7-nicotinic acetylcholine receptors , 2020, Journal of Neuroinflammation.

[26]  R. Papke,et al.  Nicotinic acetylcholine receptors: Conventional and unconventional ligands and signaling , 2020, Neuropharmacology.

[27]  Soonmi Won,et al.  Sexual dimorphism in cognitive disorders in a murine model of neuropathic pain , 2020, Behavioral and Brain Functions.

[28]  Runtao Li,et al.  Antinociceptive Effect of Spirocyclopiperazinium Salt Compound DXL-A-24 and the Underlying Mechanism , 2019, Neurochemical Research.

[29]  Wen-tao Liu,et al.  Nicotine Attenuates Osteoarthritis Pain and Matrix Metalloproteinase-9 Expression via the α7 Nicotinic Acetylcholine Receptor , 2019, The Journal of Immunology.

[30]  Huixia Wei,et al.  Activation of alpha7 acetylcholine receptors reduces neuropathic pain by decreasing dynorphin A release from microglia , 2019, Brain Research.

[31]  R. Papke,et al.  The α7 nicotinic receptor silent agonist R-47 prevents and reverses paclitaxel-induced peripheral neuropathy in mice without tolerance or altering nicotine reward and withdrawal , 2019, Experimental Neurology.

[32]  R. Papke,et al.  The α7 nicotinic acetylcholine receptor positive allosteric modulator prevents lipopolysaccharide-induced allodynia, hyperalgesia and TNF-α in the hippocampus in mice , 2019, Pharmacological reports : PR.

[33]  X. Gu,et al.  Perioperative activation of spinal α7 nAChR promotes recovery from preoperative stress-induced prolongation of postsurgical pain , 2019, Brain, Behavior, and Immunity.

[34]  Shu-Ling Wang,et al.  Alpha7 Nicotinic Acetylcholine Receptor Alleviates Inflammatory Bowel Disease Through Induction of AMPK-mTOR-p70S6K-Mediated Autophagy , 2019, Inflammation.

[35]  M. Matthias,et al.  Managing Chronic Pain in an Opioid Crisis: What Is the Role of Shared Decision-Making? , 2019, Health communication.

[36]  Yue-chun Li,et al.  Eliciting α7‐nAChR exerts cardioprotective effects on ischemic cardiomyopathy via activation of AMPK signalling , 2019, Journal of cellular and molecular medicine.

[37]  F. Gao,et al.  Targeting Cytokines for Morphine Tolerance: A Narrative Review , 2019, Current neuropharmacology.

[38]  Y. Qian,et al.  Alpha 7 nicotinic acetylcholine receptor and its effects on Alzheimer's disease , 2019, Neuropeptides.

[39]  D. Ye,et al.  The Role of CXCR3 in Neurological Diseases , 2019, Current neuropharmacology.

[40]  J. Yakel,et al.  The α7 nicotinic acetylcholine receptors regulate hippocampal adult-neurogenesis in a sexually dimorphic fashion , 2018, Brain Structure and Function.

[41]  R. Urman,et al.  Management of Challenging Pharmacologic Issues in Chronic Pain and Substance Abuse Disorders. , 2018, Anesthesiology clinics.

[42]  R. Papke,et al.  The Antinociceptive and Anti-Inflammatory Properties of the α7 nAChR Weak Partial Agonist p-CF3 N,N-diethyl-N′-phenylpiperazine , 2018, The Journal of Pharmacology and Experimental Therapeutics.

[43]  W. Maixner,et al.  Neuroinflammation and Central Sensitization in Chronic and Widespread Pain. , 2018, Anesthesiology.

[44]  Gloria Brunori,et al.  Influence of neuropathic pain on nicotinic acetylcholine receptor plasticity and behavioral responses to nicotine in rats , 2018, Pain.

[45]  R. Papke,et al.  New Insights on Neuronal Nicotinic Acetylcholine Receptors as Targets for Pain and Inflammation: A Focus on α7 nAChRs , 2018, Current neuropharmacology.

[46]  F. Carroll,et al.  Effect of nicotine and alpha‐7 nicotinic modulators on visceral pain‐induced conditioned place aversion in mice , 2018, European journal of pain.

[47]  Runtao Li,et al.  Antinociception of the spirocyclopiperazinium salt compound LXM‐15 via activating &agr;7 nAChR and M4 mAChR and inhibiting CaMKII&agr;/cAMP/CREB/CGRP signalling pathway in mice , 2018, Regulatory toxicology and pharmacology : RTP.

[48]  J. McIntosh,et al.  Nicotinic acetylcholine receptors in neuropathic and inflammatory pain , 2018, FEBS letters.

[49]  S. Mahata,et al.  &agr;7-Nicotinic Acetylcholine Receptor Agonist Ameliorates Nicotine Plus High-Fat Diet–Induced Hepatic Steatosis in Male Mice by Inhibiting Oxidative Stress and Stimulating AMPK Signaling , 2018, Endocrinology.

[50]  P. Mason,et al.  Nicotinic modulation of descending pain control circuitry , 2017, Pain.

[51]  Nicole E. Burma,et al.  Animal models of chronic pain: Advances and challenges for clinical translation , 2017, Journal of neuroscience research.

[52]  X. Gu,et al.  Spinal activation of alpha7-nicotinic acetylcholine receptor attenuates posttraumatic stress disorder-related chronic pain via suppression of glial activation , 2017, Neuroscience.

[53]  V. Echeverria,et al.  Positive modulators of the α7 nicotinic receptor against neuroinflammation and cognitive impairment in Alzheimer's disease , 2016, Progress in Neurobiology.

[54]  R. Papke,et al.  Background and Purpose Experimental Approach Conclusions and Implications , 2022 .

[55]  F. Sala,et al.  1,3-diphenylpropan-1-ones as allosteric modulators of α7 nACh receptors with analgesic and antioxidant properties. , 2016, Future medicinal chemistry.

[56]  Fei Li,et al.  Activation of Adenosine Monophosphate–activated Protein Kinase Suppresses Neuroinflammation and Ameliorates Bone Cancer Pain: Involvement of Inhibition on Mitogen-activated Protein Kinase , 2015, Anesthesiology.

[57]  M. Quik,et al.  Alpha7 nicotinic receptors as therapeutic targets for Parkinson's disease. , 2015, Biochemical pharmacology.

[58]  R. León,et al.  Anti-inflammatory role of microglial alpha7 nAChRs and its role in neuroprotection. , 2015, Biochemical pharmacology.

[59]  M. Kassiou,et al.  The Therapeutic Potential of α7 Nicotinic Acetylcholine Receptor (α7 nAChR) Agonists for the Treatment of the Cognitive Deficits Associated with Schizophrenia , 2015, CNS Drugs.

[60]  Loren J. Martin,et al.  Different immune cells mediate mechanical pain hypersensitivity in male and female mice , 2015, Nature Neuroscience.

[61]  R. Papke,et al.  The analgesic-like properties of the alpha7 nAChR silent agonist NS6740 is associated with non-conducting conformations of the receptor , 2015, Neuropharmacology.

[62]  J. Yakel,et al.  Nicotinic ACh receptors as therapeutic targets in CNS disorders. , 2015, Trends in pharmacological sciences.

[63]  Q. Yin,et al.  Nicotinic acetylcholine receptor α7 subunit is involved in the cobratoxin-induced antinociception in an animal model of neuropathic pain. , 2015, Toxicon : official journal of the International Society on Toxinology.

[64]  R. Papke,et al.  The Minimal Pharmacophore for Silent Agonism of the α7 Nicotinic Acetylcholine Receptor , 2014, The Journal of Pharmacology and Experimental Therapeutics.

[65]  Zhen-Zhong Xu,et al.  Emerging targets in neuroinflammation-driven chronic pain , 2014, Nature Reviews Drug Discovery.

[66]  C. Ghelardini,et al.  Involvement of α7 nAChR subtype in rat oxaliplatin-induced neuropathy: Effects of selective activation , 2014, Neuropharmacology.

[67]  S. AlSharari,et al.  Functional role of alpha7 nicotinic receptor in chronic neuropathic and inflammatory pain: studies in transgenic mice. , 2013, Biochemical pharmacology.

[68]  C. Ghelardini,et al.  Nicotine is a pain reliever in trauma- and chemotherapy-induced neuropathy models. , 2013, European journal of pharmacology.

[69]  F. Carroll,et al.  In vivo pharmacological interactions between a type II positive allosteric modulator of α7 nicotinic ACh receptors and nicotinic agonists in a murine tonic pain model , 2013, British journal of pharmacology.

[70]  A. Lichtman,et al.  Effects of alpha 7 positive allosteric modulators in murine inflammatory and chronic neuropathic pain models , 2013, Neuropharmacology.

[71]  F. Carroll,et al.  The Antinociceptive Effects of Nicotinic Receptors α7-Positive Allosteric Modulators in Murine Acute and Tonic Pain Models , 2013, The Journal of Pharmacology and Experimental Therapeutics.

[72]  S. Maier,et al.  Systemic administration of an alpha-7 nicotinic acetylcholine agonist reverses neuropathic pain in male Sprague Dawley rats. , 2012, The journal of pain : official journal of the American Pain Society.

[73]  D. Redden,et al.  Effects of nicotine on spinal cord injury pain vary among subtypes of pain and smoking status: results from a randomized, controlled experiment. , 2012, The journal of pain : official journal of the American Pain Society.

[74]  J. Calixto,et al.  Activation of the alpha-7 nicotinic acetylcholine receptor (α7 nAchR) reverses referred mechanical hyperalgesia induced by colonic inflammation in mice , 2012, Neuropharmacology.

[75]  Zhijun Zhang,et al.  Short-term tropisetron treatment and cognitive and P50 auditory gating deficits in schizophrenia. , 2012, The American journal of psychiatry.

[76]  J. Oestreich,et al.  Traumatic brain injury: central and peripheral role of α7 nicotinic acetylcholine receptors. , 2012, Current Drug Targets.

[77]  S. Maier,et al.  Intrathecal injection of an alpha seven nicotinic acetylcholine receptor agonist attenuates gp120-induced mechanical allodynia and spinal pro-inflammatory cytokine profiles in rats , 2010, Brain, Behavior, and Immunity.

[78]  S. Waguri,et al.  Primary sensory neuronal expression of SLURP-1, an endogenous nicotinic acetylcholine receptor ligand , 2009, Neuroscience Research.

[79]  I. Chessell,et al.  Activation of the alpha7-nicotinic acetylcholine receptor reverses complete freund adjuvant-induced mechanical hyperalgesia in the rat via a central site of action. , 2008, The journal of pain : official journal of the American Pain Society.

[80]  J. Changeux,et al.  Nicotine differentially activates inhibitory and excitatory neurons in the dorsal spinal cord , 2004, Pain.

[81]  Laure Plantard,et al.  Identification of SLURP-1 as an epidermal neuromodulator explains the clinical phenotype of Mal de Meleda. , 2003, Human molecular genetics.